Načítá se...
Population-based study on use of chemotherapy in men with castration resistant prostate cancer
BACKGROUND. Chemotherapy prolongs life and relieves symptoms in men with castration resistant prostate cancer (CRPC). There is limited information on a population level on the use of chemotherapy for CRPC. MATERIAL AND METHODS. To assess the use of chemotherapy in men with CRPC we conducted a regist...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Informa Healthcare
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3812701/ https://ncbi.nlm.nih.gov/pubmed/23427879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/0284186X.2013.770164 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|